Correction to “Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease”

IF 13 1区医学 Q1 CLINICAL NEUROLOGY

Alzheimer's & Dementia Pub Date : 2025-07-19 DOI:10.1002/alz.70467

引用次数: 0

Abstract

Leffa DT, Povala G, Bellaver B, et al. Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease. Alzheimers Dement. 2025;21(2):e70003. https://doi.org/10.1002/alz.70003

In Figures 1 and 2, “MC” is displayed instead of “MCI.” Additionally, Figure 2 is missing the percentage symbols and includes a truncated label “Biomarker po” instead of “Biomarker positivity.”

We apologize for this error.

查看原文本刊更多论文

对“阿尔茨海默病中注意力缺陷/多动障碍的多基因风险评分的影响”的更正

Leffa DT, Povala G, Bellaver B，等。阿尔茨海默病中注意力缺陷/多动障碍多基因风险评分的影响阿尔茨海默病。2025;21(2):e70003。https://doi.org/10.1002/alz.70003In图1和图2中，显示的是“MC”而不是“MCI”。此外，图2缺少百分比符号，包括截断的标记“Biomarker po”而不是“Biomarker positivity”。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Alzheimer's & Dementia 医学-临床神经学

CiteScore

14.50

自引率

5.00%

发文量

299

审稿时长

3 months

期刊介绍： Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.